These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096 [TBL] [Abstract][Full Text] [Related]
3. [Alteration of CD44v3 and CD44v6 expression in oral premalignant epithelia]. Gao Y; Liu J; Pang S Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):286-8. PubMed ID: 11776894 [TBL] [Abstract][Full Text] [Related]
4. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Bahar R; Kunishi M; Kayada Y; Yoshiga K Int J Oral Maxillofac Surg; 1997 Dec; 26(6):443-6. PubMed ID: 9418147 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451 [TBL] [Abstract][Full Text] [Related]
6. [Expression of CD44 variant 6 and its metastatic potential in squamous cell carcinoma of the oral cavity]. Kunishi M; Kayada Y; Tsumura M; Yoshiga K; Takada K Gan To Kagaku Ryoho; 1996 Jul; 23(8):1045-8. PubMed ID: 8687219 [TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Kunishi M; Kayada Y; Yoshiga K Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720 [TBL] [Abstract][Full Text] [Related]
9. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions. Heyden A; Huitfeldt HS; Koppang HS; Thrane PS; Bryne M; Brandtzaeg P J Oral Pathol Med; 1992 Jan; 21(1):7-11. PubMed ID: 1375644 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Kerdpon D; Rich AM; Reade PC Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348 [TBL] [Abstract][Full Text] [Related]
11. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Torres-Rendon A; Roy S; Craig GT; Speight PM Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805 [TBL] [Abstract][Full Text] [Related]
12. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study. Lameira AG; Pontes FS; GuimarĂ£es DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Wakulich C; Jackson-Boeters L; Daley TD; Wysocki GP Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207 [TBL] [Abstract][Full Text] [Related]
14. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia. Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. Sawant SS; Vaidya Mm; Chaukar DA; Alam H; Dmello C; Gangadaran P; Kannan S; Kane S; Dange PP; Dey N; Ranganathan K; D'Cruz AK Oral Dis; 2014 Jul; 20(5):453-65. PubMed ID: 23865921 [TBL] [Abstract][Full Text] [Related]
16. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Singh BB; Chandler FW; Whitaker SB; Forbes-Nelson AE Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jun; 85(6):692-8. PubMed ID: 9638703 [TBL] [Abstract][Full Text] [Related]
18. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity. Devoll RE; Li W; Woods KV; Pinero GJ; Butler WT; Farach-Carson MC; Happonen RP J Oral Pathol Med; 1999 Mar; 28(3):97-101. PubMed ID: 10069535 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR; Ranganathan K; Rao UK; Joshua E J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]